logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12527785 B1

PDFFull Text
Date of Patent:
Jan. 20, 2026

Filed:

Jan. 10, 2023

Renin-angiotensin-aldosterone system (raas) inhibitors in the treatment of pancreatic ductal carcinoma

Applicant:

Ochsner Clinic Foundation, New Orleans, LA (US);

Inventors:

Richard N. Re, New Orleans, LA (US);

Xin Zhang, New Orleans, LA (US);

Li Li, New Orleans, LA (US);

Assignee:

OCHSNER CLINIC FOUNDATION, New Orleans, LA (US);

Attorney:

Schwabe, Williamson & Wyatt, P.C.

Primary Examiner:

Jeffrey H Murray

Assistant Examiner:

Luisalberto undefined Gonzalez

Int. Cl.
CPC ...
A61K 31/472 (2006.01); A61K 31/4178 (2006.01); A61K 31/4184 (2006.01); A61K 31/437 (2006.01); A61P 1/18 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/472 (2013.01); A61K 31/4178 (2013.01); A61K 31/4184 (2013.01); A61K 31/437 (2013.01); A61P 1/18 (2018.01); A61P 35/00 (2018.01);
Abstract

Embodiments provide for methods of treatment for subjects suffering from a condition/disorder or disease for which the renin-angiotensin-aldosterone system (RAAS) plays at least some role. In one example, a method comprises administering to the subject an effective amount of one or more of an angiotensin receptor AT2R antagonist for a duration sufficient to elicit a desired response in the subject suffering from pancreatic cancer. The administering acts to reduce proliferation of tumor cells associated with the pancreatic cancer.

Find Patent Forward Citations

Re, Richard. (2026). Renin-angiotensin-aldosterone system (raas) inhibitors in the treatment of pancreatic ductal carcinoma (U.S. Patent No. 12527785). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12527785

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…